Novartis Investigative Site

Hokkaido 060-8648

0 studies enrolling now · 3 studies all time

What they study most

Cancer, Carcinoma, Renal Cell, Ovarian Cancer, Renal Cell Carcinoma (RCC)

Studies at this site

• Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma — Completed
• Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) — Completed